First-Line Treatment of Widely Metastatic BRAF-Mutated Salivary Duct Carcinoma With Combined BRAF and MEK Inhibition
2018 ◽
Vol 16
(10)
◽
pp. 1166-1170
◽
Keyword(s):
Keyword(s):
Keyword(s):
2019 ◽
Keyword(s):
2001 ◽
Vol 14
(2)
◽
pp. 123-131
◽
Keyword(s):